We first assessed the association of these proteins with histological subtypes of breast cancer, which revealed that both Claudin-2 and Afadin are significantly elevated in the TNBC compared with estrogen receptor (ER+) or HER2 subtypes (Supplemental Fig. S7B,C). The gene discussed is CLDN2; the disease is breast cancer.